Article Versions Notes

Sommerer C, Schmitt A, Hückelhoven-Krauss A, Giese T, Bruckner T, Wang L, Schnitzler P, Meuer S, Zeier M, Schmitt M. Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients. Vaccines. 2021; 9(2):133. https://doi.org/10.3390/vaccines9020133

Sommerer, Claudia, Anita Schmitt, Angela Hückelhoven-Krauss, Thomas Giese, Thomas Bruckner, Lei Wang, Paul Schnitzler, Stefan Meuer, Martin Zeier, and Michael Schmitt. 2021. "Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients" Vaccines 9, no. 2: 133. https://doi.org/10.3390/vaccines9020133

Sommerer, C., Schmitt, A., Hückelhoven-Krauss, A., Giese, T., Bruckner, T., Wang, L., Schnitzler, P., Meuer, S., Zeier, M., & Schmitt, M. (2021). Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients. Vaccines, 9(2), 133. https://doi.org/10.3390/vaccines9020133